Panacea Laboratories was established in 2006 to provide blood, serum, and tissue tests to diagnose and monitor cancer. Currently, Panacea Laboratories offers BC Detectsm, CC Detectsm, LC Detectsm, PC Detectsm and TK Sensesm as CLIA laboratory services.
BC Detectsm is a test which aids in the detection of recurrence of breast cancer. The ordering physician should interpret results in conjunction with results from standard-of-care surveillance.
CC Detectsm is a test which aids in the detection of colorectal cancer. The ordering physician should interpret results in conjunction with patient history, a physical exam and the results of screening tests recommended by the American Cancer Society.
LC Detectsm is a test for lung cancer screening to be used in conjunction with chest x-ray, CT scan and other imaging modalities to help identify individuals with lung cancer.
PC Detectsm is a test for prostate cancer screening to be used in conjunction with PSA and DRE to help determine the likelihood that a patient has prostate cancer.
TK Sensesm is a RT-PCR (gene expression) test that predicts the response of patients with Chronic Myelogenous Leukemia (CML) to imatinib (Gleevec®).
Future products will include serum and tissue tests to aid in the diagnosis, surveillance and monitoring of several other malignancies including liver, ovarian and other cancers.
Our facilities are regulated under the Clinical Laboratory Improvement Amendments of 1988 (CLIA).
Panacea Laboratories is a division of Panacea Pharmaceuticals, Inc.
Contact Information:
Panacea Laboratories
207 Perry Parkway
Suite 2
Gaithersburg, MD 20877
Tel.: 240-404-9045
Fax: 240-465-0450
Panacea Laboratories was established in 2006 to provide blood, serum, and tissue tests to diagnose and monitor cancer. Currently, Panacea Laboratories offers